Screenshot: C-SPAN RINO Senator Thom Tillis (R-NC) openly rebuked President Trump’s bold new plan to slash sky-high prescription drug prices during a Senate hearing on Pharmacy Benefit Managers and Drug Pricing. During a heated Senate hearing on Pharmacy Benefit Managers (PBMs) and drug pricing, Tillis took aim at Trump’s executive order, calling the “Most Favored Nation” (MFN) policy “shortsighted” and “unsustainable.” Rather than stand with working Americans crushed by obscene prescription costs, Tillis chose to parrot talking points straight from the pharmaceutical lobby’s playbook. “The ‘Most Favored Nation’ coming out of the administration, all these other things are short-sighted, unsustainable measures that are not going to produce the result. I do believe all of us on this committee want to achieve. It’s not the what,…
Click here to read the full article at The Gateway Pundit.
